Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011)

Ani Pharmaceuticals (ANIP) posted Notes Payables of $1.2 million for Q3 2011, up 3.92% sequentially from $1.2 million in Q2 2011.

Ani Pharmaceuticals (ANIP) Notes Payables (2010 - 2011) Analysis & Trends

Ani Pharmaceuticals has reported Notes Payables for 2 years, with the latest figure at $1.2 million in Q3 2011.

Quarterly Notes Payables changed N/A year-over-year to $1.2 million in Q3 2011, while the trailing twelve-month figure through Sep 2011 was $1.2 million (changed N/A YoY) and the FY2010 annual result came in at $1.1 million, changed N/A from the prior year.
Notes Payables climbed to $1.2 million in Q3 2011 per ANIP's latest filing, from $1.2 million in the prior quarter.
Over five years, Notes Payables peaked at $1.2 million in Q3 2011 and troughed at $1.1 million in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.89 Bn	42.93 Bn	-
2	Teva Pharmaceutical Industries	43.01 Bn	39.35 Bn	2.15 Bn
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn
5	United Therapeutics	22.17 Bn	19.51 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.85 Bn	1.46 Bn
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.12 Bn	9.96 Bn	-
10	Ani Pharmaceuticals	1.63 Bn	1.27 Bn	165.89 Mn

Download Data